Placebo-controlled study: Latest News, Top Stories & Analysis

DEVON, PA — Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE) announced the initiation of a pivotal, multinational randomized, double-blind, placebo-controlled, multiple-center, efficacy and safety (RECONNECT) Phase 3 trial.

Business / Research

Galera Announces Final Results from Pancreatic Cancer Trial

September 9, 2021September 9, 2021 - by MyChesCo

MALVERN, PA — Galera Therapeutics, Inc. (Nasdaq: GRTX) announced final results from its Phase 1/2 pilot trial of its dismutase mimetic, GC4419, versus placebo, in patients with unresectable or borderline …

Products and Services

Trevena Announces Publication Highlighting Risk / Benefit Analysis of OLINVYK in Pain and Therapy

August 13, 2021August 11, 2021 - by MyChesCo

CHESTERBROOK, PA —Trevena, Inc. (Nasdaq: TRVN) this week announced the publication of an exploratory analysis evaluating the safety of OLINVYK (oliceridine) injection and IV morphine, using data from the OLINVYK Phase …

Cancer / Research

Galera Announces Updated Data from Trial with Pancreatic Cancer Patients

April 30, 2021April 30, 2021 - by MyChesCo

MALVERN, PA — Galera Therapeutics, Inc. (Nasdaq: GRTX) announced updated results from its Phase 1/2 pilot trial of GC4419, versus placebo, in patients with locally advanced pancreatic cancer (LAPC) who …